Company Overview
- Website
- vaxdesign.com
- Phone
- (407) 243-5600
- Employees
- 12
- Founded in
- 2003
- Industry
- Market Research
- NAICS Codes
-
62 - Health Care and Social Assistance621 - Ambulatory Health Care Services6219 - Other Ambulatory Health Care Services62199 - All Other Ambulatory Health Care Services621991 - Blood and Organ Banks
- SIC Codes
-
80 - Health Services809 - Miscellaneous Health and Allied Services, Not Elsewhere Classified
Financials & Stats
Revenue
$7B
Recent News & Media
List of Sanofi affiliates
- Jan 31, 2025
- sanofi.com
Single-dose VSV-based vaccine protects against Kyasanur Forest disease in nonhuman primates
- Sep 6, 2023
- pmc.ncbi.nlm.nih.gov
Single-dose VSV-based vaccine protects against Kyasanur Forest disease in nonhuman primates
- Sep 6, 2023
- science.org
Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: A Phase 1 dose-escalation study in healthy adults
- Aug 10, 2023
- sciencedirect.com
Unifying in vitro and in vivo IVT mRNA expression discrepancies in skeletal muscle via mechanotransduction
- Apr 7, 2020
- pubmed.ncbi.nlm.nih.gov
Sanofi Pasteur VaxDesign Corp
- May 12, 2019
- bloomberg.com
Who is Sanofi Pasteur VaxDesign Corporation
Sanofi Pasteur VaxDesign Corporation is a subsidiary company based in Orlando, Florida. The company employs 12 people and generates an annual revenue of $7.3 million. VaxDesign focuses on the design and development of vaccines. VaxDesign is a wholly owned subsidiary of sanofi pasteur. For more information, please visit vaxdesign.com.